Page 23 - Serum Institute Of India

ICMR launches a new vaccine portal for Covid, with details of trials

The portal covers other ailments as well; will provide details of progress made locally and globally at regular intervals

Does govt have Rs 80,000 cr to buy, give out vaccine, Serum Inst chief asks

Experts say even as vaccine is being developed, govt should put in place its strategy for distribution and procurement instead of waiting for the vaccine to be ready

Serum Institute starts manufacturing Codagenix's potential Covid-19 vaccine

Serum Institute, the world's largest vaccine maker by number of doses produced, will develop Codagenix's CDX-005, which is delivered intranasally rather than via an injection

Oxford vaccine: Phase-3 trial to begin in Pune next week, volunteers enrol

Under phase-II, trials were conducted at Bharti Vidyapeeth Medical College and also KEM Hospital in the city

Serum Institute of India gets nod to resume Covid-19 vaccine trial

The resumption of trails was allowed after the vaccine maker submitted recommendations of the Data Safety Monitoring Board (DSMB), the UK, and DSMB, India

Delivering Covid vaccine a governance challenge, India should take lead

One critical challenge will be storage and transportation. Some of the vaccines that use the new messenger RNA technology will need to be stored at subzero temperatures

Serum Institute gets DCGI nod to resume clinical trial of Oxford vaccine

DCGI gave permission to Serum Institute to resume clinical trial of the Oxford Covid-19 vaccine candidate in the country

Novavax, Serum Institute to produce 2 bn Covid vaccine doses under new deal

The U.S. company's vaccine is in mid-stage trials after an early-stage trial showed it produced high levels of antibodies against the novel coronavirus

Not enough Covid-19 vaccines for everybody till 2024 end: Adar Poonawalla

Poonawalla estimates that the world will need 15 billion doses of the vaccine if it is taken in two steps

DCGI aks Serum Institute to suspend recruitment for Oxford vaccine trials

DCGI has directed Serum Institute of India to suspend till further orders new recruitment in phase 2 and 3 clinical trials of the Oxford COVID-19 vaccine candidate

Covid-19: Indian sites await DCGI nod to restart Oxford vaccine trial

The Drug Controller General of India (DCGI) V G Somani will take a call after he receives data from the Data and Safety Monitoring Board (DSMB) in the UK as well as India

Serum Institute puts India trials of AstraZeneca's Covid-19 vaccine on hold

Serum Institute of India has put trials of AstraZeneca's Covid-19 vaccine candidate on hold until the British drugmaker restarts the trials, Serum said

Covid-19: Serum Institute to halt trial of Oxford vaccine after DCGI notice

On Tuesday, AstraZeneca had decided to stop trials after a participant fell sick with an unexplained illness.

What Serum Institute's persistence on Oxford vaccine trials means for India

The company is going ahead regardless of AsraZeneca pausing trials in UK after an adverse impact was reported

Indian-origin professor's UK firm strikes Covid-19 vaccine deal with India

The firm, SpyBiotech which is led by Prof Sumi Biswas, is an Oxford University spinoff company with a novel vaccine platform to target infectious diseases, cancer and chronic diseases

Isha, Akash Ambani, Byju, Poonawalla debut on Fortune's '40 under 40' list

The list covers five sectors including finance, technology, health, government/politics and media/entertainment

When will India finally have access to coronavirus vaccine?

India commands 40 per cent of global capacity for vaccines which is estimated at 5.7 billion doses

Phase II clinical trial of Oxford Covid-19 vaccine begins in Pune

The Phase II clinical trial of the Oxford COVID-19 vaccine, being manufactured by the city-based Serum Institute of India (SII), began at a medical college and hospital here on Wednesday. Two male volunteers were administered the vaccine at Bharti Vidyapeeth's Medical College and Hospital, a senior office-bearer of the hospital said. The trial began around 1 pm, he said. "Doctors at the hospital administered the first shot of the 'Covishield' vaccine to a 32-year-old man after his reports of COVID-19 and antibodies tests came out negative," Medical Director of Bharti Vidyapeeth's Medical College, Hospital and Research Centre, Dr Sanjay Lalwani, said. Another 48-year-old male volunteer was also given the vaccine, he added. While the 32 year-old volunteer works for a private company, the other one is associated with the healthcare sector, he said. "Before administering the vaccine, doctors checked their temperature, blood pressure and heart beats," he said. Five volun

Covishield vaccine to be sold only after successful trial: Serum Institute

SII issued this clarification after reports in the media began appearing which claimed that Covishield- Oxford University's vaccine candidate, will be commercialised in a little over two months

Second Russian Covid-19 vaccine 'EpiVacCorona' shows promise: Report

The vaccine elicits an immune response after double administration with the interval of 14-21 days